Search

You searched for "ovaries"

470 results found

Demanding cases or nightmares in uro-oncology? Jan/Feb 2022

5 January 2022 | | URO - Urologic Oncology
When less is more: percutaneous biopsy and tumour seeding in papillary renal cell carcinoma Renal cell carcinoma (RCC) accounted for 2.2% of new cancer diagnoses worldwide in 2018 with over 400,000 new cases and 175,098 deaths [1]. The majority of...

Urinary biomarkers for surveillance of non-muscle invasive bladder cancer

1 May 2019 | | URO - Basic Science Research, URO - Urologic Oncology
Bladder cancer (BC) is the ninth most common cancer worldwide with a yearly incidence of approximately 430,000 cases. There is a male predominance and it is the seventh most common cancer in men worldwide [1]. Non-muscle invasive bladder cancer (NMIBC)...

The multidisciplinary team meeting: London calling!

1 January 2015 | | URO - Technology
The multidisciplinary team meeting, or MDT, is the foundation of cancer management in the UK. The MDT consists of a group of experts in different fields of medicine and surgery coming together at regular intervals to discuss the diagnosis and...

Black men are more at risk from prostate cancer, but we won’t let it stay that way – an update from Prostate Cancer Research

4 May 2023 | | URO - Urologic Oncology
- CHARITY FOCUS - Focusing on all of disease characteristics, societal factors, and better communication gives us real potential to fix a disparity that has persisted for too long. When it comes to health inequity, the numbers are stark. Black...
Journal of Endourology cover image.

A new haemostatic agent in tubeless PCNL

1 March 2014 | | URO - Endourology & Stones
Tubeless percutaneous nephrolithotomy (PCNL) is increasingly being used in carefully selected patients to reduce hospital stay and analgesia requirements, especially in those with little bleeding who become stone free or have insignificant residual fragments (usually <4mm). Various agents have been...

Artificial intelligence in bladder cancer diagnostics

2 May 2025 | | URO - Urologic Oncology
Bladder cancer (BCa), ranking as the 10th most common cancer worldwide, poses a significant health burden with high morbidity and mortality [1]. Timely tumour detection and accurate evaluation are crucial for effective management, as the prognosis is dependent on the...

A sigma six approach to improving nephrostomy and antegrade stent services at a district general hospital – an audit project

12 September 2023 | | URO - Trauma & Emergency
As hospitals merge into larger trusts there becomes a centralisation of some services. Interventional radiology (IR) has been one of those services. Our district general hospital runs bi-weekly lR lists following service centralisation. Urology and IR most commonly liaise on...

British Urology Researchers in Surgical Training research collaborative: A BURST of ideas and endeavours

1 March 2019 | | URO - Basic Science Research, URO - Endourology & Stones, URO - Urologic Oncology
The British Urology Researchers in Surgical Training (BURST) research collaborative was founded in 2015 with the aim of creating research opportunities for urology trainees in the UK. It was built on early foundations laid out by the Thames Research Urologists...

medac Pharma launch education platform, medac Academy

8 April 2022 | Research & Development, Company Profiles
medac Pharma have launched a new digital education platform for UK healthcare professionals, medac Academy.

New CPD Course Advances LATP Biopsy Skills for Clinicians

9 May 2025 | Company Profiles, Research & Development
Mermaid Medical, in collaboration with Fujifilm, recently delivered the first session of a new CPD-accredited training course focused on Local Anaesthetic Transperineal Prostate (LATP) biopsy procedures. Hosted at the advanced Fujifilm House in Bedford, the workshop welcomed healthcare professionals for...

Consensus statements on PSA testing in asymptomatic men in the UK

1 May 2016 | | URO - Urologic Oncology
In January 2016, the UK National Screening Committee once again recommended against a systematic population screening programme for prostate cancer due to the, as yet, insufficient evidence that the benefits of screening would outweigh the harm to the population as...

Sexual dysfunction following prostate cancer treatment

4 March 2024 | | URO - Andrology, URO - Urologic Oncology
Prostate cancer is common with over 52,300 new cases diagnosed annually in the UK; this is expected to rise by 15% between 2023-2025 and 2038-2040 [1]. Radical prostatectomy continues to be the most common form of radical treatment for men...